Verastem Oncology (VSTM) Misses Q1 EPS by 79c

Verastem Oncology (NASDAQ: VSTM) reported Q1 EPS of ($0.79).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Thunder Mountain Gold closes $5.7M private placement
• UDynamics files for Nasdaq IPO of 5.6 million shares at $5-$7 per share